A Phase II Study of Docetaxel, Oxaliplatin and S-1 (DOS) in Patients With Advanced Gastric Cancer
Phase of Trial: Phase II
Latest Information Update: 17 Dec 2015
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 04 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Oct 2011 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 18 Sep 2007 New trial record.